Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 21, 2025 09:07 ET | Source: Research and Markets

Greece Construction Industry Report 2025: Output to Grow by 2.3% this Year, Supported by Investments in Transport, Electricity Infrastructure, and Increase in Building Permits - Forecast to 2029

Dublin, May 21, 2025 (GLOBE NEWSWIRE) -- The "Greece Construction Market Size, Trends, and Forecasts by Sector - Commercial, Industrial, Infrastructure, Energy and Utilities, Institutional and...
May 15, 2025 07:00 ET | Source: GH Research PLC

GH Research Announces Acceptance of Pharmaceutical Pipeline Presentation and Late-Breaking Posters at the American Society of Clinical Psychopharmacology 2025 Annual Meeting

DUBLIN, May 15, 2025 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing...
May 13, 2025 21:09 ET | Source: PhenQ

PhenQ + PhenQ PM Under Review: Powerful Fat Burner Supplements for Day & Night Weight Loss

Las Vegas, May 13, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: The top reasons weight loss supplements fail and why most solutions don’t address both day and night fat-burning...
May 08, 2025 13:59 ET | Source: Purerawz

Purerawz Under Review Best-in-Class Highest Quality SARMs & Peptides For Sale in USA by Pure Rawz

New York, May 08, 2025 (GLOBE NEWSWIRE) -- In This Article, You'll Discover: Why do many researchers struggle to find high-quality SARMs and peptides for sale in the USAThe most common pitfalls...
May 08, 2025 07:00 ET | Source: GH Research PLC

GH Research Reports First Quarter 2025 Financial Results and Provides Business Updates

Primary endpoint met in Phase 2b trial with GH001 in TRD demonstrating -15.5 Point placebo-adjusted MADRS reductionFull response to the IND hold on track for submission in mid-2025Cash, cash...
May 08, 2025 04:36 ET | Source: Research and Markets

Major Depressive Disorder Pipeline Report 2025: Comprehensive Insights of 75+ Companies and Drugs Under Clinical Assessment

Dublin, May 08, 2025 (GLOBE NEWSWIRE) -- The "Major Depressive Disorder - Pipeline Insight, 2025" has been added to ResearchAndMarkets.com's offering. This report offers an extensive examination...
May 05, 2025 08:30 ET | Source: SNS Insider pvt ltd

Acromegaly Treatment Market Size to Hit USD 2.88 Billion by 2032, Growing at 5.71% CAGR – SNS Insider

Austin, May 05, 2025 (GLOBE NEWSWIRE) -- Acromegaly Treatment Market Trends & Growth Analysis: According to SNS Insider, the global acromegaly treatment market was valued at USD 1.76 billion...
April 30, 2025 07:57 ET | Source: TestoPrime

Best Testosterone Booster Supplement for Males Over 40: Why TestoPrime Leads for Muscle, Energy & Libido

New York City, April 30, 2025 (GLOBE NEWSWIRE) -- Introduction: Why Testosterone Support Matters After 40 As men age, maintaining strength, stamina, and masculinity becomes increasingly difficult...
April 28, 2025 15:06 ET | Source: Ghaf Group

Faculty Group and Ghaf Capital Announce Strategic Merger to Launch Web3 Powerhouse, Ghaf Group

DUBAI, United Arab Emirates, April 28, 2025 (GLOBE NEWSWIRE) -- In a landmark move, Faculty Group and Ghaf Capital today announced their merger to form Ghaf Group, a vertically integrated Web3...
April 24, 2025 10:32 ET | Source: OBI Pharma Inc.

OBI Pharma kündigt Posterpräsentationen auf der AACR-Jahrestagung 2025 zu den Antikörper-Wirkstoff-Konjugaten (AWK) OBI-992 und OBI-902, den ADC-Enabling-Technologien GlycOBI® und ThiOBI®, dem Prodrug OBI-3424 und der Globo-H-Forschung (GH-Forschung) an

TAIPEH, Taiwan, April 24, 2025 (GLOBE NEWSWIRE) -- OBI Pharma, Inc. (TPEx: 4174. TWO), hat heute nichtklinische Daten zu OBI-902 bekannt gegeben, einem potenziell in seiner Klasse führenden...